LEP and fatty liver disease: The assessment of the prevalence of metabolic disturbances (lipid and carbohydrate disorders), metabolic-associated fatty liver disease, arterial hypertension, and metabolic syndrome will be performed, and their correlation with BMI z-score, bio-impedance data, and leptin and bioactive leptin level will be performed.